Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
about
Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular BlockadeUse of neuromuscular blockers and neostigmine for general anesthesia and its association with neuraxial blockade: A retrospective studyDiscovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.Evaluation of neostigmine antagonism at different levels of vecuronium-induced neuromuscular blockade in isoflurane anesthetized dogs.Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.Conceptual and technical insights into the basis of neuromuscular monitoring.Effect of isoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade and hemodynamic responses by cisatracurium bolus injection.Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgeryDose-reversal effect relationship of three different doses of neostigmine in obese patients: A randomised clinical trial.Neuromuscular monitoring and the cost of antagonism: when will we learn?Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.Timing of reversal with respect to three nerve stimulator end-points from cisatracurium-induced neuromuscular block.Comparison of train-of-four count by anesthesia providers versus TOF-Watch® SX: a prospective cohort study.Neuromuscular Block and Blocking Agents in 2018.
P2860
Q26741519-5EA7A8D9-48DF-47D0-911D-448DD71B6DCDQ33879788-7B5DB779-F3A8-4FCF-B50A-0417FF497126Q34613962-4E507A41-2B17-41E0-A9FD-C236BCE55C34Q37490317-652E5E66-A7E9-4F2A-B5B2-BAA56AA3DD17Q38707992-6EE9633B-63D0-484E-8A04-14256B48DD77Q39065381-A527ED06-246F-4E9E-B0C5-FCDD7C8E9105Q39214272-11369FB1-88D5-4792-A0C7-9D2D913DBB21Q41055020-563CA760-8378-4500-B519-19B7AB2C6FDDQ47108975-B17CCEFF-9426-4636-916F-5A2A41945E61Q47231588-D14106A2-7957-4D97-94CC-ED288A43484CQ47590900-0C25152F-2FC4-4EF5-B921-709E492C6EDBQ47626160-7FC215DB-29DA-45DB-B8FC-190083567B1AQ47669033-4AC3A249-7C46-4064-8DBB-9D4DA4D44AC3Q55215771-B7203836-2CBB-460E-94AF-8B29AF5E2465
P2860
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@en
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@nl
type
label
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@en
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@nl
prefLabel
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@en
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@nl
P2093
P1433
P1476
Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
@en
P2093
Hans Kirkegaard
James E Caldwell
P356
10.1097/00000542-200201000-00013
P407
P577
2002-01-01T00:00:00Z